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he presence of nonprogressive cognitive impairment is recognized as a common feature in a substantial
roportion of patients with Duchenne muscular dystrophy. To investigate the possible role of mutations
long the dystrophin gene affecting different brain dystrophin isoforms and speciﬁc cognitive proﬁles, 42
school-age children affected with Duchenne muscular dystrophy, subdivided according to sites of
mutations along the dystrophin gene, underwent a battery of tests tapping a wide range of intellectual,
linguistic, and neuropsychologic functions. Full-scale intelligence quotient was approximately 1 S.D.
below the population average in the whole group of dystrophic children. Patients with Duchenne
muscular dystrophy and mutations located in the distal portion of the dystrophin gene (involving the
140-kDa brain protein isoform, called Dp140) were generally more severely affected and expressed
different patterns of strengths and impairments, compared with patients with Duchenne muscular
dystrophy and mutations located in the proximal portion of the dystrophin gene (not involving Dp140).
Patients with Duchenne muscular dystrophy and distal mutations demonstrated speciﬁc impairments in
visuospatial functions and visual memory (which seemed intact in proximally mutated patients) and
greater impairment in syntactic processing.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Duchenne muscular dystrophy is a fatal, recessive, X-linked
muscular disease affecting about 1 in 3500 liveborn human males
[1,2]. In Duchenne muscular dystrophy, the body is unable to
produce the dystrophin protein as a result of a large variety of
mutations/deletions of the dystrophin gene. The protein is essential
for muscle contraction, and its absence leads to progressive muscle
weakness, chronic degeneration, and replacement of the muscle
with fat and endomysial ﬁbrosis.
The presence of nonprogressive cognitive impairment is widely
recognized as a common feature in a substantial proportion of
patients. Interestingly, delay in global developmental and language
disorders can constitute the signs of onset in this disease [3].k.
ngelo; Neuromuscular Unit;
e Cura a Carattere Scientiﬁco
sio Parini, Lecco, Italy.
-NC-ND license.A meta-analysis performed by Emery and Muntoni [4] docu-
mented intelligence quotients in 721 patients with Duchenne
muscular dystrophy, and indicated that the overall mean intelli-
gence quotient was 82 (approximately 1 S.D. below the population
mean). Nineteen percent demonstrated an intelligence quotient
below 70 (i.e., the generally accepted cutoff point for a diagnosis of
mental retardation), and 3% demonstrated an intelligence quotient
of less than 50 (indicating moderate to severe mental retardation).
A discrepancy between verbal intelligence quotient and
performance intelligence quotient, with greater impairment of
verbal components, is widely described [5]. Verbal disability con-
sisting of poor expressive verbal abilities, deﬁcits in short-term
memory, and speciﬁc disabilities in learning to read, write, and
calculate, with relatively intact visuospatial cognitive abilities, are
more frequently reported cognitive deﬁcits in English-speaking and
French-speaking children with Duchenne muscular dystrophy [6-
9]. Some authors point to deﬁcits in verbal working memory [9]
and in phonologic processing [10,11] as the main sources of difﬁ-
culty in these patients’ verbal processing.
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trophin, a 427-kDa protein associated with sarcolemma in skeletal
and smooth muscle and two alternative 427-kDa isoforms are also
expressed in the cerebral neocortex. In the cerebellum, dystrophin
appears to play a role in normal neuronal function or development.
Two carboxy-terminal dystrophin proteins (Dp), Dp71 and Dp140,
are both expressed in the brain, in addition to full-length central
nervous systemdystrophins, and are initiatedbetweenexons62 and
63, and upstream from exon 44, respectively [12-14].
Rearrangements in the second part of the dystrophin gene tend to
be more commonly associated with cognitive impairment, and
several reports described mutations in the Dp71 coding region as
a factor thatcontributes to theseverityofmental retardation,andmay
account for shift in intelligence quotient of 2 S.D.s downward [13-15].
Moreover, a lack of the Dp140 isoform is thought to play
a signiﬁcant role in cognitive performances in both Duchenne
muscular dystrophy [16,17] and Becker muscular dystrophy [18].
However, apart from general intellectual abilities, a lack of
consensus exists on the correlation between dysfunction in the
dystrophin gene and a speciﬁc neuropsychologic proﬁle.
The present study investigated possible similarities and differ-
ences in the cognitive proﬁles of Italian-speaking, school-age chil-
dren with Duchenne muscular dystrophy, with different mutation
sites along the dystrophin gene, i.e., distal vs proximal (down-
stream and upstream from exon 44, involving or sparing the
expression of Dp140, respectively). We hypothesized that different
mutations along the dystrophin gene not only inﬂuence intellectual
levels, but also determine speciﬁc neuropsychologic proﬁles.
Materials and Methods
Participants
Forty-two children affected with Duchenne muscular dystrophy and 10 boys
affected with spinal muscular atrophy and osteogenesis imperfecta (severe
muscular impairments not related to a deﬁciency of dystrophin) were enrolled in
the study. All parents gave informed consent. This study was approved by our local
Human Ethics Committee, according to the declaration of Helsinki.
All patients had clinical, histologic, and immunohistologic features compatible
with a diagnosis of Duchenne muscular dystrophy. The identiﬁcation of the
responsible abnormalities in the dystrophin gene conﬁrmed the diagnosis [2,19]. At
the time of their evaluation, 19 children with Duchenne muscular dystrophy were
ambulant, and 23 were wheelchair-bound.
The control group comprised children with a diagnosis of spinal muscular
atrophy (deﬁned via clinical and neurophysiologic signs, molecular alterations in the
Survival Motor Neuron 1 gene) [20,21] or of osteogenesis imperfecta (deﬁned via
clinical signs, radiologic ﬁndings, and genetic or biochemical analysis) [22,23]. All
patients were boys, including six with osteogenesis imperfecta (four were
wheelchair-bound, and two were ambulant) and four with spinal muscular atrophy
(twowere wheelchair-bound, and twowere ambulant), and all demonstratedmotor
impairments similar to those in the group of children with Duchenne muscular
dystrophy. The mean age in the group with Duchenne muscular dystrophy was 9.1
years (S.D., 1.6 years). The mean age in the control group was 9.6 years (S.D., 1.6
years) (t(50) ¼ 0.845, no signiﬁcance).
For both groups, the inclusion criteria comprised an age ranging between 6-12
years, normal hearing, and the absence of severe visual impairment (the reliability of
results of cognitive and linguistic tests may be impaired by visual deﬁcits). The age
range of subjects was chosen to allow for the administration of cognitive and
linguistic tests, standardized for an Italian population.
None of the children were habitually bilingual. All were attending mainstream
schools. Twenty percent of the children in both groups with Duchenne muscular
dystrophy (with a deletion in the distal and the proximal portions of the Duchenne
muscular dystrophy gene; see below) received psychoeducational support.
Home and educational environments were comparable for all children. In every
group, most of the parents (ranging from 65-80%) had graduated from high school,
and around 10% had graduated from college. The sociodemographic characteristics
of the families were similar across groups.
Genetic analysis
We extracted DNA from peripheral blood samples according to standard
procedures, using a commercial kit (Flexi Gene DNA Handbook, Qiagen [Hilden,Germany]). Deletions were deﬁned via multiplex polymerase chain reactions. In
some patients, multiplex ligation-dependent probe ampliﬁcation [24] was also
performed, to screen for deletions and duplications. A direct sequence analysis of all
dystrophin gene-coding exons and surrounding splicing sites was performed to
detect point mutations and other microrearrangements.
On the basis of the localization of molecular abnormalities along the dystrophin
gene, mutations located in (or extending to) the genomic region corresponding to
exons 45-55 of the dystrophin gene are considered to affect Dp140 (as well as Dp427
and Dp260; these proteins are not relevant to our study), but not Dp71. Mutations in
the dystrophin gene, located upstream from exon 44, are predicted to preserve
Dp140 and to affect only the expression of Dp427 and Dp260 [15].
Patients with Duchenne muscular dystrophy were further subdivided into two
groups: 17 children (“Duchenne muscular dystrophy proximal”) carried mutations
in the 50 end of the Duchenne muscular dystrophy gene (upstream from exon 44),
with 1/17 duplications, 4/17 point mutations, and 12 deletions; 25 children
(“Duchenne muscular dystrophy distal”) carried mutations in the 30 end of the
Duchennemuscular dystrophy gene (downstream from exon 44), with the following
distribution: 1 /25 duplications, 2/25 point mutations, and 22 deletions.
The group of distally deleted children consisted of 24 boys bearing mutations
predicted to affect all dystrophin products, including Dp140 but not Dp71, and one
boy with a mutation affecting the expression of Dp140 and Dp71.
Fourteen children in the Duchenne muscular dystrophy distal group were
wheelchair-bound, and 11 were ambulant. In the Duchenne muscular dystrophy
proximal group, nine were wheelchair-bound, and eight were ambulant. Only one
patient in the Duchenne muscular dystrophy distal group presented with mild
cardiac involvement, and one child in the Duchenne muscular dystrophy proximal
group presented a very severe clinical phenotypewith mild respiratory insufﬁciency
at the time of his examination.
The mean age in the two groups was comparable (Duchenne muscular dystrophy
distal, mean age, 8.8 years; S.D., 1.4 years; Duchenne muscular dystrophy proximal,
mean age, 9.5 years; S.D., 1.8 years; t40¼ 1.25, no signiﬁcance). A similar percentage
of children treated with steroids was present in the two groups, i.e., 16 of 25 children
of the distal group (35%), and 12 of 17 children in the proximal group (32%).
Cognitive assessment
General intelligence was assessed using the Wechsler Intelligence Scale for
Children-Revised. This version of the Wechsler scales was used because it was the
only version currently adapted and normed for the Italian population as of the time
we initiated the study [25]. The results are expressed as intelligence quotient scores
(mean, 100; S.D., 15) for the Verbal and the Performance scales, and as scaled scores
(mean, 10; S.D., 3) for single subtests. Further neuropsychologic and neurolinguistic
tests were administered to test speciﬁc functions.
Language abilities
A battery of standardized tests for the assessment of language development in
Italian children was used, i.e., the Batteria 4-12 (a battery for the linguistic assess-
ment of children aged 4-12 years) [26]. A number of single tests are included in the
battery.
In terms of comprehension, the verbal auditory discrimination of subjects was
assessed by the Same-Different Judgment Test, a phonemic identity judgment task.
Semantic comprehension was assessed by means of a picture identiﬁcation test,
adapted from the British Picture Vocabulary Scale [27]. Morpho-syntactic compre-
hension was assessed with the Test of Grammatical Comprehension for Children
[28], a sentence-picture matching test. Syntactic comprehension was assessed with
the Italian version of the Token Test [27].
Productionwas assessedwith a naming task requiring subjects to name 36 object
pictures [27] and the Test of Semantic Fluency, in which subjects are prompted to
name, in the course of 90 seconds, as many words as possible belonging to the
“animals” and “home objects” semantic categories. An additional test of derivational
morphology, taken from the Test of Morpho-Syntactic Development [29], requires
subjects to produce derived forms of given terms.
Repetition abilities were assessed by means of a Sentence Repetition task
[30,31]. An additional test of Word and Nonword Repetitionwas taken from the Test
of Morpho-Syntactic Development [29].
Reading abilities
Text reading was assessed with the Prove di Rapidità e Correttezza Nella Lettura
del Gruppo MT (a test for speed and accuracy in reading, as developed by the
Memory Training Group) [32]. Scores in speed and accuracy are recorded.
Single word/nonword reading subtests were taken from the Batteria per la
Valutazione della Dislessia e Disortograﬁa Evolutiva (the Battery for the Assessment
of Developmental Reading and Spelling Disorders) [33]. Scores of speed and accu-
racy in reading lists of words and nonwords were recorded.
Neuropsychologic assessment: Attention
Visual attention was assessed via the Visual Attention Subtest of the Develop-
mental Neuropsychological Assessment (NEPSY) [34], a visual search task in which
total scores are computed from speed and accuracy scores.
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Attention and Response Set, requiring subjects to displace sets of colored tokens
from one box to another one while listening to a series of spoken words.
Neuropsychologic assessment: Memory
Visual/verbal cross-modal memory was assessed by means of the Memory for
Names Subtest of the Test di Memoria e Apprendimento battery (an Italian adap-
tation of the Test of Memory and Learning) [35], requiring subjects to learn and
recall the names of eight children whose faces are depicted in line drawings.
Verbal learning, supraspan memory, and resistance to interference were
assessed via the List Learning Subtest of the Test of Memory and Learning [35]. This
test assesses the immediate recall of word lists over repeated trials with or without
interference, as well as a delayed recall after 30 minutes.
Visual memory was assessed with the Abstract Visual Memory Subtest from the
Test of Memory and Learning [35], requiring the immediate recognition of abstract,
nonverbalizable pictures. All scores are expressed as z-scores.
Data analysis
The two groups of children with Duchenne muscular dystrophy with distal and
proximal mutations were compared in terms of various cognitive and neuro-
psychologic measures. Subsequent analyses were performed to better deﬁne: (1) the
degree of impairment of the two subgroups compared with control patients, and (2)
the relationship of the deﬁcits highlighted in either subgroup with other theoreti-
cally relevant cognitive and neuropsychologic functions. SPSS software (SPSS, Inc,
Chicago, IL) was used for all analyses.Results
Our study showed that in Italian-speaking children with
Duchenne muscular dystrophy, the intelligence quotient is
approximately 1 S.D. below the population average, with an overall
mean full-scale intelligence quotient of 86.43  13.7, and
a discrepancy between verbal intelligence quotient (86.26  14.9)
and performance intelligence quotient (89.98  14.8). The control
group of patients with spinal muscular atrophy or osteogenesis
imperfecta (severely motor impaired) did not manifest any cogni-
tive deﬁcits, with a full-scale intelligence quotient of 107.7  10.45,
a verbal intelligence quotient of 108  9.34, and a performance
intelligence quotient of 105.6  16.
Separate analyses, taking into account genetic alterations in the
dystrophin gene (Duchenne muscular dystrophy distal and
Duchenne muscular dystrophy proximal), indicated that the verbal
intelligence quotients of both groups were signiﬁcantly lower than
those of the control children, whereas only distally mutated chil-
dren with Duchenne muscular dystrophy demonstrated signiﬁ-
cantly lower performance intelligence quotients (Table 1).
In the Duchenne muscular dystrophy distal group, 24 of 25
patients carried mutations predicted to affect all dystrophin prod-
ucts, including Dp140 but not Dp71. Only one patient carried
a mutation also affecting Dp71. That patient did not exhibit deﬁcitsTable 1. Scores of Wechsler Intelligence Scales in two groups of children with Duch
muscular dystrophy proximal) and the control group
Duchenne Muscular
Dystrophy, Distal
Duchenne Muscular
Dystrophy, Proxima
VIQ 86.8  16.8 85.5  12.2
PIQ 86.5  13.8 95.1  14
FSIQ 84.8  14.5 88.9  12.6
Abbreviations:
FSIQ ¼ Full-scale intelligence quotient
PIQ ¼ Performance intelligence quotient
VIQ ¼ Verbal intelligence quotient
Mean scores obtained on the Wechsler Intelligence Scale-Revised are indicated as mean
(P < 0.05).
* Duchenne muscular dystrophy distal group vs control group.
y Duchenne muscular dystrophy proximal group vs control group.in any neurocognitive function. Moreover, his full-scale intelligence
quotient was above 100.
We further analyzed data from four additional patients who
carried mutations affecting the Dp71 region, but who did not meet
to the inclusion criteria of this study. Two were older than 12 years
of age, and twowere younger than 6 years of age at the time of their
evaluation. Their full-scale intelligence quotients ranged from 62-
88. We emphasize that the lowest full-scale intelligence quotient
score (51) in the whole sample was observed in a child carrying
a mutation affecting the expression of Dp140, but not the expres-
sion of Dp71.
Amore detailed analysis of theWechsler subscales revealed some
interesting and completely new differences in cognitive proﬁles in
the two subgroups of patients with Duchenne muscular dystrophy
(Fig 1). Patients in the Duchenne muscular dystrophy distal group
scored signiﬁcantly lower than patients of the Duchenne muscular
dystrophy proximal group in Digit Span (t(26.83) ¼ 3.627, P ¼
0.001), Picture Arrangement (t(32) ¼ 2.419, P ¼ 0.021), and Object
Assembly (t(32) ¼ 2.075, P ¼ 0.046). Children in the Duchenne
muscular dystrophy proximal group tended (albeit not signiﬁcantly)
to score lower than those in theDuchennemuscular dystrophy distal
group on Comprehension (t(38) ¼ 1.777, P ¼ 0.08). All these differ-
ences tended to retain (for Digit Span, Picture Arrangement, and
Object Assembly, P¼ 0.009, P¼ 0.025, and P¼ 0.064, respectively) or
even improve (Comprehension subtest, P¼ 0.006) their signiﬁcance
when full-scale intelligence quotient was used as a covariate in the
analysis (toassess thespeciﬁc componentsof reported impairments).
No Bonferroni correction was applied, because the variables are
obviously intercorrelated.
Compared (using t tests) with control subjects, patients in the
Duchenne muscular dystrophy distal group scored signiﬁcantly
lower (P < 0.03) on all verbal subtests except on Comprehension,
while patients in the Duchenne muscular dystrophy proximal
group scored lower (P < 0.03) on all verbal subtests except Digit
Span. In terms of Performance subtests, the children with distally
mutated Duchenne muscular dystrophy performed signiﬁcantly
worse than control subjects in Picture Completion, Picture
Arrangement, Block Design, and Coding (P < 0.05), whereas the
children with proximally mutated Duchenne muscular dystrophy
did not differ from control subjects on any subtest (P > 0.05).
Concerning scores obtained on language tests, comparisons
between subgroups were repeated, controlling for the effect of full-
scale intelligence quotient (set as a covariate in an analysis of
variance).
As depicted in Fig 2, both subgroups demonstrated deﬁcits in all
linguistic functions, with distally mutated patients obtaining gener-
ally lower scores than proximally mutated patients. Only scores inenne muscular dystrophy (Duchenne muscular dystrophy distal and Duchenne
l
Control Subjects Pairwise Comparison
(Tukey Post Hoc Tests)
108  9.3 0.001*
0.001y
105.6  16 0.002*
107.7  10.4 <0.001*
0.002y
s  S.D. Different symbols indicate pairs that demonstrated signiﬁcant differences
Figure 1. Top: WISC-R verbal subscale. Mean scaled scores (y-axis) were obtained in verbal scale subtests (x-axis) in each group (DMD distal, DMD proximal, and control group).
Bottom: WISC-R performance subscale. Mean scaled scores (y-axis) were obtained in performance scale subtests (x-axis) in each group (DMD distal, DMD proximal, and control
groups). DMD, Duchenne muscular dystrophy; WISC-R, Wechsler Intelligence Scale-Revised.
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two subgroups (F (1.40) ¼ 5.667, P ¼ 0.02), and this difference was
conﬁrmedwhen intelligence quotientwas entered as a covariate into
the analysis (F (1.39) ¼ 5.07, P ¼ 0.03). In comparison with controlsubjects, including intelligence quotient as covariate, we observed
that all differences became nonsigniﬁcant, with the exception of
Fluency for patients with distally mutated Duchenne muscular
dystrophy (though yielding z-scores greater than 0).
Figure 2. Performance of DMD subgroups (DMD distal and DMD proximal) and control
group in linguistic tests. DMD, Duchenne muscular dystrophy; SE, standard error.
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(with Bonferroni correction, a ¼ 0.01) in the two subgroups of
patients with Duchenne muscular dystrophy (Fig 3), patients with
both distally and proximally mutated Duchenne muscular
dystrophy performed at a lower level than control subjects in Visual
Attention, whereas only patients with distally mutated Duchenne
muscular dystrophy exhibited deﬁcits in Visual Abstract Memory.
The difference in Visual Memory between the two subgroups was
not signiﬁcant (t(40) ¼ 1.936, P ¼ 0.06), and trended further from
signiﬁcance when intelligence quotient was entered as a covariate
(P ¼ 0.10). Moreover, the differences between patients with distally
mutated Duchenne muscular dystrophy and control subjects con-
cerning Auditory Attention (though with z-scores greater than 0;
t (32)¼ 2.603, P¼ 0.012), Visual Attention (t(33)¼ 3.476, P¼ 0.001),
andVisualMemory (t(33)¼3.552, P¼0.001) becamenonsigniﬁcantFigure 3. Neuropsychologic proﬁles of control, DMD distal, and DMD proximal
patients. DMD, Duchenne muscular dystrophy; SE, standard error.(P > 0.25) when intelligence quotient was included as a covariate.
Children with proximally mutated Duchenne muscular dystrophy
performed (almost signiﬁcantly) worse than control subjects on
VisualAttentiononly (t(25)¼2.452,P¼0.022), but thisdifference, in
contrast with the ﬁndings for the Duchenne muscular dystrophy
distal group, appeared to be independent of inﬂuences from intel-
ligence quotients. Interestingly, no deﬁcits in Auditory Attention,
List Learning, and Memory for Names were evident in any of the
subgroups.
Finally, the two groups of control patients and patients with
Duchenne muscular dystrophy were compared on tests of reading
accuracy and speed. The results are reported in Fig 4. No Bonferroni
correction was applied, because all measures were highly inter-
correlated. The children with Duchenne muscular dystrophy
appeared to be particularly slow in reading text and words, and
partly slow in reading nonwords. However, the reading perfor-
mances were rather similar in the two groups with Duchenne
muscular dystrophy, and no signiﬁcant differences were evident
between distally and proximally mutated children. Taken sepa-
rately, the Duchennemuscular dystrophy distal group performed at
a signiﬁcantly lower level than control subjects in text reading
speed (t(30) ¼ 2.135, P ¼ 0.041), and the same held true for the
Duchenne muscular dystrophy proximal group (t(25) ¼ 2.229, P ¼
0.035). In both groups, variations in intelligence quotient, entered
in the analysis as a covariate, explained all differences.Correlations
The patterns of correlations between reading skills and other
linguistic or neuropsychologic functions were also investigated, to
evaluate whether different sources of impairment were identiﬁable
in the two subgroups of children with Duchenne muscular
dystrophy. The scores of different language tests pertaining to
a common language domain were averaged into global scores. We
ensured that the variables considered to be part of the samedomain,
beyond theoretical justiﬁcations, were indeed characterized by highFigure 4. Reading performances in control, DMD distal, and DMD proximal patients.
DMD, Duchenne muscular dystrophy; SE, standard error.
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Word and Nonword Repetition scores were averaged to express
a Phonological Skills score. The Token Test, Grammatical Compre-
hension, and Sentence Repetition scores were averaged to express
a Syntactic Skills score. Passive Vocabulary, Naming, Derivational
Morphology, and Verbal Fluency were averaged to express a Lexical
Skills score. Similarly, reading scores fromWord, Nonword, and Text
Readingwere averaged into aReading Speed andaReadingAccuracy
global score.
First, Pearson’s correlations were computed for reading scores
with subtests of the Wechsler Intelligence Scale for Children-
Revised, revealing interesting associations for the Duchenne
muscular dystrophy distal group between reading accuracy and
information (r ¼ 0.476, P ¼ 0.022), as well as between reading
speed and Picture Arrangement (r ¼ 0.487, P ¼ 0.025). In the
Duchennemuscular dystrophy proximal group, only one signiﬁcant
correlation emerged between reading accuracy and arithmetic (r ¼
0.557, P ¼ 0.025). Further associations emerged, in the proximal
group only, between reading speed and lexical skills (r ¼ 0.558, P ¼
0.02), phonologic skills (r ¼ 0.492, P ¼ 0.045), and visual memory
(r ¼ 0.616, P ¼ 0.009), and also between reading accuracy and
syntactic skills (r ¼ 0.657, P ¼ 0.004). No signiﬁcant correlations
emerged for the distal group (r < 0.31, in all cases). The predicted
correlations between Reading Speed and Digit Span scores, which
were highly signiﬁcant for the control group (r ¼ 0.755, P ¼ 0.03),
appeared to be negligible for both groups with Duchenne muscular
dystrophy (r < 0.3 in all cases, for both speed and accuracy in
reading).Discussion
A number of ﬁndings suggest that rearrangements located in the
second part of the dystrophin gene are more often associated with
cognitive impairment than mutations in the proximal part. Indeed,
distal macrodeletions in the dystrophin gene (altering Dp140
expression) are usually associated with cognitive impairment [16-
18], and mutations involving the Dp71 region are often associated
with severe cognitive impairment [13,15,36,31].
To investigate thepossible relationshipbetweenmutations in the
dystrophin gene affecting the Dp140 brain dystrophin isoform and
speciﬁc cognitive proﬁles, 42 school-age childrenwith a clinical and
molecular diagnosis of Duchenne muscular dystrophy were ﬁrst
subdivided according to site of mutations, and then accurately
characterizedat the cognitive level throughabatteryof tests tapping
a wide range of intellectual, linguistic, and neuropsychologic
functions.
Intelligence quotients in the whole group were in general
accordance with data reported in the literature, with an overall
mean full-scale intelligence quotient approximately 1 S.D. below
the population average, although the discrepancy between verbal
intelligence quotient and performance intelligence quotient was
more limited than that described in some previous studies [5,9,14].
Our control group of patients with spinal muscular atrophy and
osteogenesis imperfecta was severely motor impaired but did not
exhibit any cognitive deﬁcits, thus conﬁrming that motor impair-
ment does not inﬂuence intellectual abilities, as already demon-
strated by Billard et al. [10].
Separate analyses taking into account the genetic alterations in
the dystrophin gene (Duchenne muscular dystrophy distal and
Duchenne muscular dystrophy proximal) indicated that the verbal
intelligence quotients in both groups were signiﬁcantly lower than
those of control children, whereas only children in the distally
mutated Duchennemuscular dystrophy group showed signiﬁcantly
lower performance intelligence quotients.Patients with distal mutations were generally more severely
affected and manifested different patterns of strengths and
impairments, in comparison to patients with proximal mutations.
In particular, distal mutations seem to produce greater deﬁcits
in verbal short-termmemory, as expressed by lowDigit Span scores
(and possibly working memory, which may also be responsible for
the lowperformances in the Picture Arrangement subtest), in visual
memory, and in visuospatial organization, as expressed by lower
scores on the Performance subtests of the Wechsler Intelligence
Scale for Children-Revised, especially in Object Assembly, and also
in logical sequencing (Picture Arrangement). On the other hand,
patients with mutations in the proximal portion of the dystrophin
gene demonstrated relative strengths in verbal short-termmemory
(as measured by the Digit Span subtest) and in the Performance
subtests of the Wechsler scales, especially Object Assembly, Mazes,
and Picture Arrangement (requiring visuospatial organization and
planning), whereas they exhibited some difﬁculties in social judg-
ment and the critical appreciation of general statements (as
measured by the Comprehension subtest). Furthermore, dystrophic
children with distal mutations manifested clear difﬁculties in
syntactic processing, as expressed by both Token Test and Gram-
matical Comprehension scores. Finally, lower scores in Visual
Memorywere also an exclusive characteristic of patients with distal
mutations, whereas deﬁcits in Visual Attention were common to
both subgroups.
Analyses controlling for the inﬂuence of general intellectual
deﬁcits on speciﬁc linguistic, neuropsychologic, and academic
functions revealed that most of the deﬁcits were substantially
explained by variations in intelligence quotients. The only excep-
tions were difﬁculties in Syntactic Comprehension, which were
characteristic of patients with Duchenne muscular dystrophy distal
mutations, and deﬁcits in Visual Attention among patients with
proximal mutations.
Surprisingly, reading performances did not reﬂect the same
pattern of differences. Children with distal and proximal mutations
demonstrated very similar patterns and degrees of impairment in
reading. Interesting differences, however, appeared in the patterns
of correlations of reading skills with other cognitive and neuro-
psychologic functions. Children with distal mutations in the
Duchenne muscular dystrophy gene exhibited positive associations
between reading accuracy and long-termmemory functions (in the
Information subtest of theWechsler Intelligence Scale for Children-
Revised), as well as between reading speed and logical sequencing
abilities (Picture Arrangement). Children with proximal mutations
in the Duchenne muscular dystrophy gene, on the other hand,
demonstrated associations between reading speed and lexical and
phonologic competence, and with visual memory, whereas reading
accuracy correlated with syntactic skills and some computational
skills (working memory and auditory attention were excluded,
because no associations were evident with their speciﬁc measures)
measured by the Arithmetic subtest of the Wechsler Intelligence
Scale for Children-Revised.
In dystrophic patients with distal mutations, deﬁcits in
academic ability seem to involve primarily verbal long-term
memory, and these deﬁcits seem to be relatively independent of
their (severe) limitations in linguistic and visuospatial abilities.
The great amount of heterogeneity usually described for
cognitive and intellectual functions in the population with
Duchenne muscular dystrophy may thus be largely dependent on
the two genetic and functional types being intermingled within
groups.
In summary, apart from a general greater impairment in all
cognitive functions for dystrophic patients with distal mutations,
speciﬁc differences concern visuospatial functions and visual
memory, which seem to be intact in proximally mutated patients,
M.G. D’Angelo et al. / Pediatric Neurology 45 (2011) 292e299298and syntactic processing, which is impaired in both groups, but
more severely in the distally mutated group.
Thus, the present data, obtained directly through a thorough
and wide-ranging cognitive assessment (different from previous
analyses based on academic achievement), support the hypothesis
of a relationship between cognitive impairment and a lack of
Dp140. In particular, the lack of Dp140 seems to produce speciﬁc
deﬁcits in visuospatial abilities, verbal and visual memory, and
syntactic skills, whereas general verbal deﬁcits are also evident in
the presence of Dp140. The precise, differential effects of different
mutation sites on the expression of dystrophin-related products in
the brain remain to be clariﬁed.
The expression of the dystrophin gene in the central nervous
system is complex, and is characterized by alternate Duchenne
muscular dystrophy mitochondrial RNA transcripts produced from
different promoters that, together with tissue-speciﬁc alternate
mitochondrial RNA splicing, produce a complex of dystrophin
gene-related protein expression [37]. The developmental stage,
distribution, and function of Duchenne muscular dystrophy gene
products in the central nervous system, although not well charac-
terized, are thought to be different for each isoform. We postulate
that differences in neuropsychologic proﬁles among our patients
are attributable to the number and type of brain-expressed iso-
forms affected. The brain-speciﬁc Dp140 is expressed mainly in
fetal tissue and in low quantity in adult brain [38], and is suggested
to play a role in the regulation of neuroglial-speciﬁc gene expres-
sion of the 50 ﬂanking region of genomic DNA adjacent to the Dp140
ﬁrst exon, containing a variety of transcription factor-binding
motifs [39]. On the other hand, the expression of Dp71 gradually
increases from the embryonic to the adult stage. Dp71 becomes the
major product of dystrophin in the brain, particularly in the
hippocampus and some layers of the cerebral cortex. The function
of Dp71 remains unknown [40,41], and it is mainly recovered in
synaptic membranes, microsomes, and to a lesser extent, synaptic
vesicles and mitochondria [42]. Studies of Dp71-deﬁcient mice
suggest a role of this brain isoform in the formation or stabilization
of the dystrophin-associated complex [43] and in signaling
complexes at glutaminergic synapses and in synaptic maturation
and function [44].
The present data may shed some light on the great heteroge-
neity observed in cognitive functions of the population with
Duchenne muscular dystrophy. As mentioned by Taylor et al. [36],
however, even if the site of a mutation in the Duchenne muscular
dystrophy gene constitutes an important determinant for the risk of
cognitive impairment, the variability in cognitive deﬁcits among
children with Duchenne muscular dystrophy does not allow for
a classiﬁcation of the risk of cognitive disabilities based on struc-
tural features (deletions before or after a speciﬁc exon). In the
present sample, both the lowest and highest full-scale intelligence
quotients were observed in childrenwith a mutation causing a lack
of Dp140, but sparing the expression of Dp71. On the other hand,
the second highest verbal intelligence quotient (i.e., 118) was
observed in a child with mutations affecting both the Dp140 and
Dp71 isoforms. Our results are not in complete agreement with
those of Muntoni et al., who reported that all patients with a lack of
Dp71 demonstrated severe cognitive deﬁcits [45]. Furthermore, the
clear impairments of both verbal and visual memory functions in
dystrophic children with distal mutations (lacking Dp140 but not
Dp71) suggest that Dp140, and not only Dp71, is related to hippo-
campal functions.
Our results suggest that the relationship between speciﬁc dys-
trophin isoforms and cognitive impairments is complex, and that
the resultant deﬁcits are not simply the sum of negative effects
from either isoform. We also think it reasonable to presume that
other elements beyond Dp140 and Dp71 must be considered, tounderstand the neuropsychologic effects of a lack of dystrophin in
the brain.
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